My current COVID-19 research spans NIH- and CDC-funded projects for novel diagnostic and infection prevention and control (IPC) technology development, immune profiling of patient and community cohorts, and implementation of SARS-CoV-2 testing programs in underserved community settings. My research team in the Emerging Pathogens Laboratory collaborates with the Emerging Threats Epidemiology Group (UNMC College of Public Health) to manage a portfolio of health care- and community-based clinical research studies to characterize host and pathogen aspects of emerging infectious diseases of public health concern. I also lead a team within the Global Center for Health Security to develop and implement innovative tools and strategies to strengthen IPC in frontline health care facilities and outbreak response settings (innovateipc.org).